HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 11.25
-0.12 (-1.06%)
Jul 9, 2026, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 9.76 billion as of July 9, 2026. Its market cap has increased by 33.72% in one year.
Market Cap
9.76B
Enterprise Value
7.26B
Revenue
1.23B
Ranking
n/a
PE Ratio
13.14
Stock Price
11.25
Market Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 9.76B, an increase of 15.35%. That is a compound annual growth rate of 2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 9.76B | -3.98% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenFleet Therapeutics (Shanghai) | 12.65B |
| Ascletis Pharma | 12.24B |
| TenNor Therapeutics (Suzhou) | 10.17B |
| Nanjing Leads Biolabs | 9.92B |
| Everest Medicines | 9.62B |
| CARsgen Therapeutics Holdings | 9.10B |
| Suzhou Ribo Life Science | 8.85B |
| CStone Pharmaceuticals | 8.55B |